Best Biopharma Outsourcing Companies in North Rhine Westphalia, Germany
The 41 best Biopharma Outsourcing companies in North Rhine Westphalia, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Chimera Biotec.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in North Rhine Westphalia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Chimera Biotec Company offering bioanalytical services and immunoassay platforms for ultra sensitive large-molecule… | $1M | 120 mo ago | Funding Raised | Mark Spengler CEO | 2001 | TYPO3 CMSPHPLeaflet+9 | 20 patents Quantitative molecular diagnostics using conjugated detection complexes for target analyte measurement | — |
| 2 | Taros Provider of drug discovery services | $573K | 94 mo ago | Funding Raised | — | 1999 | Cart FunctionalityWordPressMySQL+20 | — | — |
| 3 | acromion Full service clinical CRO | $419K | 116 mo ago | Funding Raised | Oana Braun Founder & MD | 2002 | — | — | — |
| 4 | Profil Provider of clinical research services for diabetes and obesity studies | $226K | 56 mo ago | Funding Raised | Med Leona Plum-Mörschel Chief Executive Officer | 1999 | HubSpot CMS HubSentryWistia+12 | 2 patents Paper-based folded‑edge roller packaging with integrated humidity indicator | 2 expansions |
| 5 | Plasmid Factory Contract developer and manufacturer of Plasmid DNA | — | 47 mo ago | Public | — | 2000 | Node.jsTailwind CSSGSAP+14 | 3 patents Patents concentrated in chemistry & materials | 1 partnership |
| 6 | ARTES Biotechnology Recombinant protein production, process and vaccine development from microbial expression systems | — | 147 mo ago | Series B | — | 2002 | WordPressMySQLPHP+22 | 18 patents Yeast-based production and purification of virus-like particles and recombinant protein therapeutics | — |
| 7 | Pharmatching B2B Internet Platform connecting seekers and providers of pharma and biotech services | — | 190 mo ago | Funding Raised | Gabriele Dallmann Co-Founder & ex-CEO | 2009 | — | — | — |
| 8 | A & M Group GLP bioanalytical and cGMP analytical testing services for drug development | — | — | Unfunded | Hartmut Fischer Co-Founder | 1990 | WordPressPleskApple iCloud Mail+21 | — | — |
Top 7 Biopharma Outsourcing companies in North Rhine Westphalia
#1
Funding Raised · Neuss, North Rhine Westphalia · founded 1999 · 201 employees$226.4Kraised▾
Provider of clinical research services for diabetes and obesity studies. The organization conducts pharmacodynamic, pharmacokinetic, biosimilar, safety, and tolerability studies. It also performs bridging studies. The organization offers expertise in developing treatments for diabetes mellitus type 1 and type 2.
- Dec 2021Grant (prize money)$216.4K
- Sep 2012Grant (prize money)$10K
#2
Funding Raised · Dortmund, North Rhine Westphalia · founded 2001 · 11 employees$1.4Mraised▾
Chimera Biotec has developed a proprietary immunoassay platform called Imperacer for ultra-sensitive large molecule bioanalysis. The company claims to be the world's leading Immuno-PCR (IPCR) based technology vendor. The company's products include the Imperacer Workstation, Assay Development Kits and maintenance kit. Services offered include assay development, method validation, and bioanalysis.
- Sep 2016Grant (prize money)$225K
- Mar 2016Grant (prize money)$75K
- May 2015Grant (prize money)$918.9K
- Apr 2015Grant (prize money)$226.3K
#3
Funding Raised · Dortmund, North Rhine Westphalia · founded 1999 · 61 employees$572.8Kraised▾
Provider of drug discovery services
- Nov 2018Grant (prize money)—
- Feb 2016Grant (prize money)$271.5K
- Jan 2015Grant (prize money)$301.3K
#4
Funding Raised · Frechen, North Rhine Westphalia · founded 2002 · 44 employees$418.9Kraised▾
acromion is a full-service Contract Research Organization (CRO) offers support in developing pharmaceuticals, biologics and medical devices, both for the human and the veterinary market. The company provides integrated services in clinical trial organization and conduct, clinical monitoring, clinical data management, statistics, quality assurance and medical writing for phase I to IV clinical and non-interventional (NIS) trials.
- Jan 2017Grant (prize money)$418.9K
#5
Public · Bielefeld, North Rhine Westphalia · founded 2000 · 31 employees—raised▾
PlasmidFactory is a contract manufacturer of Plasmid DNA for research, preclinical, clinical and commercial manufacturing purposes. They offer different grades of plasmids for research & preclinical studies (4 different grades) and commercial manufacturing purposes. Their High-Quality Grade plasmid DNA can be used in the GMP production of recombinant viruses, antibodies, induced pluripotent stem cells (iPS) and RNA used for clinical studies. The company claims that it can produce high-purity DNA, whose quality markedly exceeds that of kit-based systems, due to their unique capillary gel electrophoresis (CGE) technology which allows determination and quantification of the proportion of the ccc (covalently closed circular) form, which is the most reliable active conformation. They also offer specialised plasmids such as Helper Packaging Plasmids (for Adeno Associated Virus production), reporter genes, minicircle DNA(with only the gene of interest and its regulating sequence motifs).
- Sep 2022PE—
#6
Series B · Langenfeld, North Rhine Westphalia · founded 2002 · 22 employees—raised▾
ARTES is a pharmaceutical technology provider specialized in recombinant protein production, process and vaccine development from microbial expression systems and markets the unique METAVAX (dHepB-VLP) technology in combination with yeast expression. ARTES platform is applicable for large and multimeric antigens and is able to create chimeric VLPs. In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850-sqm S1 facilities in Langenfeld.
- May 2014Series B—
#7
Funding Raised · Cologne, North Rhine Westphalia · founded 2009—raised▾
Pharmatching.com has dveeloped an easy to use platform that helps academic and pharmaceutical researchers looking for outsourcing their research services to CROs, CMOs and testing service providers who can offer such services. The company has over 11,500+ service providers which includes 1400+ preclinical CROs, 1800+ clinical CROs, 3160+ CMOs, 3400+ analytical testing labs, among others. Companies on the platform are spread all over the globe and offer their services for the development and commercialization of drugs, biologics, generics, medical devices, nutraceuticals, cosmeceuticals and veterinary medicine. The company offers one stop shop solutions which include matchmaking, collaboration tool for procurement and outsourcing, and several other applications and claims itself to be the google for the pharma and biotech industry requirements. The company also offers advertising options for sellers.
- Nov 2010Grant (prize money)—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Germany
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.
- Heidelberg University85
- German Cancer Research Center49
- Ludwig-Maximilians-Universität München48
- Technical University of Munich43
- Karlsruhe Institute of Technology33
- Gene3→29
- Mutant3→19
- Transcription (linguistics)3→16
- Messenger RNA1→14
- Immune system1→12
- Gene3→20
- Agriculture2→12
- Extracellular1→11
- Immune system1→11
- Transcriptome1→9
- Antibiotic resistance2→9
- Gene1→7
- Agriculture4→9
- Antimicrobial1→4
- Microbiome1→4
Where biotechnology is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Germany
Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.
- Immatics Biotechnologies4872
- BASF Plant Science3982
- BASF SE3543
- Boehringer Ingelheim INT3438
- Merck Patent3133
- MAX Planck Gesellschaft1799
- Evonik Degussa1680
- Amgen RES Munich1665
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.